Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections.
作者信息
Qassim Suelen H, Chemaitelly Hiam, Ayoub Houssein H, AlMukdad Sawsan, Tang Patrick, Hasan Mohammad R, Yassine Hadi M, Al-Khatib Hebah A, Smatti Maria K, Abdul-Rahim Hanan F, Nasrallah Gheyath K, Al-Kuwari Mohamed Ghaith, Al-Khal Abdullatif, Coyle Peter, Kaleeckal Anvar Hassan, Shaik Riyazuddin Mohammad, Latif Ali Nizar, Al-Kuwari Einas, Jeremijenko Andrew, Butt Adeel A, Bertollini Roberto, Al-Romaihi Hamad Eid, Al-Thani Mohamed H, Abu-Raddad Laith J
机构信息
Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Doha, Qatar.
World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
出版信息
J Travel Med. 2022 Sep 17;29(6). doi: 10.1093/jtm/taac068.
Abstract
摘要
相似文献
1
Effects of BA.1/BA.2 subvariant, vaccination and prior infection on infectiousness of SARS-CoV-2 omicron infections.BA.1/BA.2 亚变体、疫苗接种及既往感染对新型冠状病毒奥密克戎感染传染性的影响
J Travel Med. 2022 Sep 17;29(6). doi: 10.1093/jtm/taac068.
2
SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022.2020 年至 2022 年，香港科兴或康希诺疫苗接种、感染或突破性感染人群血清中对 SARS-CoV-2 奥密克戎变异株 BA.2 的中和作用。
Euro Surveill. 2022 May;27(18). doi: 10.2807/1560-7917.ES.2022.27.18.2200178.
3
Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study.丹麦全国性观察研究：与 SARS-CoV-2 奥密克戎亚变体 BA.2.86 和后代 JN.1 相关的相对疫苗保护、疾病严重程度和症状。
Lancet Infect Dis. 2024 Sep;24(9):964-973. doi: 10.1016/S1473-3099(24)00220-2. Epub 2024 May 15.
4
Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections.奥密克戎 BA.5 对先前感染奥密克戎 BA.1/BA.2 后接种疫苗人群的中和作用。
Emerg Infect Dis. 2022 Dec;28(12):2575-2577. doi: 10.3201/eid2812.221304. Epub 2022 Nov 8.
5
Durability of neutralization against Omicron subvariants after vaccination and breakthrough infection.接种疫苗和突破性感染后对奥密克戎亚变体的中和作用持久性。
Cell Rep. 2023 Feb 28;42(2):112075. doi: 10.1016/j.celrep.2023.112075. Epub 2023 Jan 27.
6
COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore.新加坡奥密克戎亚变体 BA.1/2 波期间，多发性硬化症、AQP4 抗体 NMOSD 和 MOGAD 患者接受 SARS-CoV-2 mRNA 疫苗接种后的 COVID-19 感染。
J Neurol. 2023 Jun;270(6):2817-2825. doi: 10.1007/s00415-023-11692-4. Epub 2023 Apr 7.
7
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.恢复期血清和疫苗血清及单克隆抗体对 SARS-CoV-2 奥密克戎亚变种 BA.1 和 BA.2 的中和作用有限。
EBioMedicine. 2022 Aug;82:104158. doi: 10.1016/j.ebiom.2022.104158. Epub 2022 Jul 11.
8
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control study.医护人员中，mRNA 疫苗接种与未接种者，初次感染奥密克戎（B.1.1.529）BA.1 或 前奥密克戎 SARS-CoV-2 对 BA.2 再感染的保护作用：一项病例对照研究。
Lancet Infect Dis. 2023 Jan;23(1):45-55. doi: 10.1016/S1473-3099(22)00578-3. Epub 2022 Sep 21.
9
Cross-neutralizing antibody against emerging Omicron subvariants of SARS-CoV-2 in infection-naïve individuals with homologous BNT162b2 or BNT162b2(WT + BA.4/5) bivalent booster vaccination.感染前个体中针对 SARS-CoV-2 新兴奥密克戎亚变种的交叉中和抗体，同源 BNT162b2 或 BNT162b2(WT+BA.4/5) 二价加强针接种。
Virol J. 2024 Mar 21;21(1):70. doi: 10.1186/s12985-024-02335-9.
10
Estimated Effectiveness of Prior SARS-CoV-2 BA.1 or BA.2 Infection and Booster Vaccination Against Omicron BA.5 Subvariant Infection.既往感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）BA.1或BA.2毒株及接种加强针疫苗对奥密克戎BA.5亚变体感染的估计有效性
JAMA Netw Open. 2023 Mar 1;6(3):e232578. doi: 10.1001/jamanetworkopen.2023.2578.
引用本文的文献
1
Assessing healthy vaccinee effect in COVID-19 vaccine effectiveness studies: a national cohort study in Qatar.评估新冠病毒疫苗有效性研究中的健康接种者效应：卡塔尔的一项全国队列研究。
Elife. 2025 Jun 9;14:e103690. doi: 10.7554/eLife.103690.
2
Viral load dynamics in asymptomatic and symptomatic patients during Omicron BA.2 outbreak in Shanghai, China, 2022: A longitudinal cohort study.2022年中国上海奥密克戎BA.2毒株疫情期间无症状和有症状患者的病毒载量动态变化：一项纵向队列研究
Virol Sin. 2024 Dec;39(6):851-859. doi: 10.1016/j.virs.2024.10.001. Epub 2024 Oct 11.
3
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.解决严重急性呼吸综合征冠状病毒2（SARS-CoV-2）再感染定义中的偏差：低估问题的影响。
Front Med (Lausanne). 2024 Mar 11;11:1363045. doi: 10.3389/fmed.2024.1363045. eCollection 2024.
4
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.美国成年人社区前瞻性队列研究中疫苗接种前和接种期间 SARS-CoV-2 感染的血清学发生率。
Sci Rep. 2024 Jan 5;14(1):644. doi: 10.1038/s41598-023-51029-9.
5
Protection from infection and reinfection due to the Omicron BA.1 variant in care homes.护理院中因奥密克戎 BA.1 变异株而产生的感染和再感染防护。
Front Immunol. 2023 Oct 23;14:1186134. doi: 10.3389/fimmu.2023.1186134. eCollection 2023.
6
Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adults.在美国成年人社区前瞻性队列中，疫苗推出之前及期间SARS-CoV-2感染的血清学发病率。
medRxiv. 2023 Oct 2:2023.09.29.23296142. doi: 10.1101/2023.09.29.23296142.
7
History of primary-series and booster vaccination and protection against Omicron reinfection.初级系列和加强针接种史与奥密克戎再感染的保护作用。
Sci Adv. 2023 Oct 6;9(40):eadh0761. doi: 10.1126/sciadv.adh0761. Epub 2023 Oct 4.
8
The prevalence of SARS-CoV-2 infection and other public health outcomes during the BA.2/BA.2.12.1 surge, New York City, April-May 2022.2022年4月至5月纽约市BA.2/BA.2.12.1疫情激增期间的新冠病毒感染流行率及其他公共卫生结果
Commun Med (Lond). 2023 Jun 30;3(1):92. doi: 10.1038/s43856-023-00321-w.
9
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.奥密克戎变异株与新冠前变异株相比，既往感染 SARS-CoV-2 在预防再感染和 COVID-19 严重并发症方面的作用：系统评价。
BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3.
10
Association Between Cycle Threshold Value and Vaccination Status Among Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Cases in Ontario, Canada, in December 2021.2021年12月加拿大安大略省严重急性呼吸综合征冠状病毒2奥密克戎变种病例中循环阈值与疫苗接种状况之间的关联
Open Forum Infect Dis. 2023 May 22;10(6):ofad282. doi: 10.1093/ofid/ofad282. eCollection 2023 Jun.
本文引用的文献
1
Household transmission of SARS-CoV-2 Omicron variant of concern subvariants BA.1 and BA.2 in Denmark.丹麦关注的 SARS-CoV-2 奥密克戎变体 BA.1 和 BA.2 亚变体的家庭传播。
Nat Commun. 2022 Sep 30;13(1):5760. doi: 10.1038/s41467-022-33498-0.
2
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar.mRNA 疫苗预防卡塔尔奥密克戎 BA.1 和 BA.2 亚变种对 SARS-CoV-2 的保护持续时间。
Nat Commun. 2022 Jun 2;13(1):3082. doi: 10.1038/s41467-022-30895-3.
3
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.mRNA 疫苗加强剂对卡塔尔奥密克戎感染的保护效果。
N Engl J Med. 2022 May 12;386(19):1804-1816. doi: 10.1056/NEJMoa2200797. Epub 2022 Mar 9.
4
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections.SARS-CoV-2 疫苗突破性感染、再感染和原发感染的相对传染性。
Nat Commun. 2022 Jan 27;13(1):532. doi: 10.1038/s41467-022-28199-7.
5
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020.2020 年 1 月至 5 月期间，英国 COVID-19 病例的传染性持续时间及其与 RT-PCR 循环阈值的相关性。
Euro Surveill. 2020 Aug;25(32). doi: 10.2807/1560-7917.ES.2020.25.32.2001483.
Zotero 插件